Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT03174197 · COMPLETED
Trial details
- NCT number
- NCT03174197
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2025-09-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.